| PERIOD ENDING | 31-Dec-08 | | Total Revenue | 1,255,309 | | Cost of Revenue | 1,179,397 | | | Gross Profit | 75,912 | | | Operating Expenses | | Research Development |
-
| | Selling General and Administrative | 47,428 | | Non Recurring |
-
| | Others |
-
| | | | Total Operating Expenses |
-
| | | | Operating Income or Loss | 28,484 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| | Earnings Before Interest And Taxes | 28,484 | | Interest Expense | 13,147 | | Income Before Tax | 15,337 | | Income Tax Expense | 5,594 | | Minority Interest |
-
| | | | Net Income From Continuing Ops | 9,743 | | | Non-recurring Events | | Discontinued Operations |
-
| | Extraordinary Items |
-
| | Effect Of Accounting Changes |
-
| | Other Items |
-
| | | | Net Income | 9,743 | | Preferred Stock And Other Adjustments |
-
| | | Net Income Applicable To Common Shares | $9,743 |
|
0.49% Nasdaq 0.00%
Income Statement
